Table 1 Baseline demographic and clinical characteristics of the study population
Control group (n = 15) | Prehabilitation group (n =14) | p-value | |
|---|---|---|---|
Age (years), mean ± SD | 63.8 ± 7.6 | 65.1 ± 10.2 | 0.689 |
BMI (kg/m2), mean ± SD | 27.2 ± 5.7 | 29.3 ± 6.1 | 0.360 |
Disease stage, n (%) | |||
III | 8 (53.3) | 7 (50.0) | 0.858 |
IV | 7 (46.7) | 7 (50.0) | |
Medical history, n (%) | |||
Heart disease | 2 (13.3) | 1 (7.1) | 0.584 |
Diabetes | 2 (13.3) | 3 (21.4) | 0.564 |
Anticoagulation | 2 (13.3) | 0 (0) | 0.157 |
Smoking | 6 (40.0) | 3 (21.4) | 0.270 |
Alcohol | 2 (13.3) | 0 (0) | 0.157 |
ASA class, n (%) | |||
II | 6 (40.0) | 9 (64.3) | 0.323 |
III | 8 (53.3) | 5 (35.7) | |
IV | 1 (6.7) | 0 (0) | |
Time between diagnosis and interval surgery (weeks), mean ± SD [range] | 15.3 ± 3.2 [11.3–24.3] | 13.5 ± 2.0 [11.4–18.0] | 0.097 |